The cysteinyl leukotrienes have long been suspected to play a role in
the pathogenesis of asthma. This speculation was based largely on thei
r release in human lung following antigen challenge as well as their p
otent bronchoconstrictor activity. However, there is increasing eviden
ce that the cysteinyl leukotrienes also produce several pro-inflammato
ry effects and alter the activity of neuronal pathways in the airways.
Douglas Hay, Theodore Torphy and Bradley Undem review these recent da
ta and discuss the therapeutic possibilities of cysteinyl leukotriene
receptor antagonists and 5-lipoxygenase inhibitors.